Genetic Study of Atrial Fibrillation and Heart Function Recovery
Part of Heart & circulation clinical trials.
This study looks at genetic factors in people with atrial fibrillation (an irregular heartbeat) and weak heart function to understand why some people's hearts recover after treatment and others don't. Researchers will collect blood samples and medical information to identify genetic patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have persistent atrial fibrillation (irregular heartbeat lasting more than a few seconds) before undergoing a catheter ablation procedure or cardioversion (electrical treatment to restore normal heartbeat)
- You have not had a heart attack, inherited heart disease, or primary valve disease that caused your weak heart function
- You are not pregnant and have not been pregnant in the 12 months before your heart weakness started
- You drink 21 units of alcohol per week or less (roughly 10 drinks or fewer per week)
- You have not received chemotherapy drugs that damage the heart
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how the heart's electrical signals work in people with hypertrophic cardiomyopathy (a condition where the heart muscle becomes thickened) who also have atrial fibrillation (a type of irregular heartbeat). The goal is to understand these signals better during a planned ablation procedure, which is a treatment to fix the irregular rhythm.
This study uses a genetic test to identify who might develop atrial fibrillation (an irregular heartbeat) in the future. Researchers believe certain genetic patterns combined with health factors can help predict this condition early, which could lead to better prevention.
This study looks at the genes of people whose heart muscle becomes weak due to a fast or irregular heartbeat (atrial fibrillation or flutter). The goal is to better understand why this happens in some people and not others.
This study looks for unique metabolic patterns in people with atrial fibrillation (an irregular heartbeat). The goal is to develop personalized prevention strategies by comparing these patterns between patients and healthy volunteers.
This study compares two different treatment strategies for atrial fibrillation (an irregular heartbeat) in people who also have heart failure. One strategy uses medications only, while the other includes a procedure to restore normal heart rhythm. The goal is to find the best way to improve symptoms and outcomes.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
Hear when a new Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.